API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.indianpharmapost.com/news/venus-remedies-expands-global-presence-with-marketing-authorisation-for-enoxaparin-from-azerbaijan-15007
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/venus-remedies-gets-marketing-approval-for-anticoagulant-drug-in-saudi-arabia/articleshow/103138194.cms
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214646
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/venus-remedies-gets-good-manufacturing-certification-from-saudi-drug-regulator/articleshow/98267076.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214856
https://www.suanfarma.com/en/products/heparin-crude-a-biological-material/
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-08-2021-1638945311.pdf
https://www.pharmacompass.com/pdf/news/sandoz-inc-issues-nationwide-recall-of-one-lot-of-enoxaparin-sodium-injection-usp-40mg04-ml-1638766823.pdf
https://www.europeanpharmaceuticalreview.com/news/165579/oral-milvexian-reduces-risk-of-postoperative-venous-thromboembolism/
https://www.fiercebiotech.com/biotech/bristol-myers-janssen-look-to-phase-3-as-anticoagulant-med-aces-proof-concept-study
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-17-2021-1613546616.pdf
https://www.pharmacompass.com/pdf/news/apotex-corp-issues-voluntary-nationwide-recall-of-enoxaparin-sodium-injection-1612588889.pdf
https://www.prnewswire.com/news-releases/apotex-corp-issues-voluntary-nationwide-recall-of-enoxaparin-sodium-injection-usp-due-to-mislabeling-of-syringe-barrel-measurement-markings-301220724.html
https://www.biospectrumasia.com/news/39/16714/taiwan-reports-first-covid-19-patient-recovery-with-eind-silmitasertib-treatment.html
https://www.fiercepharma.com/pharma-asia/china-s-fosun-rallies-support-for-a-joint-bid-for-bayer-s-animal-health-unit-report
https://www.fiercepharma.com/pharma/amphastar-squeezes-partners-momenta-sandoz-for-59-9m-lovenox-settlement
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078990
https://www.fiercepharma.com/marketing/esc-johnson-johnson-admits-double-xarelto-flop-blood-clot-heart-failure-studies
https://endpts.com/following-fda-win-portola-loses-ceo-william-lis/
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-17-2018-1516166737.pdf
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Lovenox_and_associated_names/human_referral_000412.jsp&mid=WC0b01ac05805c516f
http://www.fiercepharma.com/pharma/sec-sweeps-up-another-biopharma-tipster-for-insider-trading
http://www.fiercepharma.com/story/big-pharmas-cardiovascular-sales-aint-what-they-used-be/2015-05-07
https://www.gov.uk/drug-device-alerts?keywords=&alert_type%5B%5D=company-led-drugs&issued_date%5Bfrom%5D=&issued_date%5Bto%5D=